Cargando…
New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease mediated by T cells and is becoming a serious public health threat. Despite the increasing incidence rate of T1D worldwide, our understanding of why T1D develops and how T cells lose their self-tolerance in this process remain limited. Recent advances i...
Autores principales: | Zhang, Mengdi, Zhou, Yanyan, Xie, Zhiguo, Luo, Shuoming, Zhou, Zhiguang, Huang, Jiaqi, Zhao, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226440/ https://www.ncbi.nlm.nih.gov/pubmed/35757405 http://dx.doi.org/10.3389/fendo.2022.914136 |
Ejemplares similares
-
Characterization of lncRNA Profiles of Plasma-Derived Exosomes From Type 1 Diabetes Mellitus
por: Pang, Haipeng, et al.
Publicado: (2022) -
rs3806265 and rs4612666 of the NLRP3 Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes
por: Sun, Xiaoxiao, et al.
Publicado: (2022) -
Advances in Knowledge of Candidate Genes Acting at the Beta-Cell Level in the Pathogenesis of T1DM
por: Pang, Haipeng, et al.
Publicado: (2020) -
Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy
por: Yin, Wenfeng, et al.
Publicado: (2022) -
Diabetic Cardiomyopathy: An Immunometabolic Perspective
por: Mishra, Paras K., et al.
Publicado: (2017)